ADAR1 Capital Management’s Tectonic Therapeutic TECX Stock Holding History

ADAR1 Capital Management’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$498K	Buy	14,501 +1,500	+12%	+$44.1K	0.02%	212
2026 Q1	$402K	Sell	13,001 -17,006	-57%	-$419K	0.02%	218
2025 Q4	$626K	Sell	30,007 -26,000	-46%	-$483K	0.05%	175
2025 Q3	$879K	Sell	56,007 -17,498	-24%	-$361K	0.08%	106
2025 Q2	$1.46M	Buy	73,505 +10,902	+17%	+$221K	0.22%	67
2025 Q1	$1.11M	Buy	62,603 +3,895	+7%	+$127K	0.21%	77
2024 Q4	$2.71M	Sell	58,708 -68,451	-54%	-$2.89M	0.54%	41
2024 Q3	$3.85M	Sell	127,159 -229,719	-64%	-$4.2M	0.63%	32
2024 Q2	$5.88M	Buy	356,878 +27,307	+8%	+$437K	1.11%	18
2024 Q1	$5.06M	Buy	329,571 +325,392	+7,786%	+$5.15M	1.15%	14
2023 Q4	$68.2K	Buy	+4,179	New	+$71.7K	0.02%	105

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

ADAR1 Capital Management's TECX Position: Q2 2026 in Review

ADAR1 Capital Management increased its Tectonic Therapeutic (TECX) stake by 12% in Q2 2026, buying an estimated $44.1K and bringing the position to 14,501 shares worth $498K. The position accounts for 0.02% of the portfolio, ranked #212.

ADAR1 Capital Management first reported a position in TECX in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.88M in Q2 2024. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

ADAR1 Capital Management held 14,501 shares of Tectonic Therapeutic worth $498K as of Q2 2026.
ADAR1 Capital Management bought 1,500 Tectonic Therapeutic shares in Q2 2026, an estimated $44.1K.
Tectonic Therapeutic made up 0.02% of ADAR1 Capital Management's portfolio in Q2 2026, its #212 holding.
ADAR1 Capital Management first reported a position in Tectonic Therapeutic in Q4 2023 and has held it in 11 quarters since.
ADAR1 Capital Management's Tectonic Therapeutic position peaked at $5.88M in Q2 2024.
123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.